Catch a vibe: A PrEP study for HIV prevention
This study looks at how well long-acting injectable PrEP (a shot that prevents HIV) works for people who are at risk for HIV. Researchers want to understand the experience of patients and the healthcare staff who support them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You do not have HIV and are at risk for HIV infection
- You are starting or already on long-acting injectable PrEP (the prevention shot)
- You identify as a Black or Latinx cisgender woman, a Black or Latinx man who has sex with men, or as a transgender or nonbinary person
- You live in New York State and speak English or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help Black men in NYC who have sex with men access HIV testing and prevention pills. Your participation could help make HIV prevention easier to get for you and your community.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study looks at a long-acting injectable HIV prevention medication (called cabotegravir) to see how well it works in real life. If you are already taking or starting this shot, you may be able to join and help improve HIV prevention care.
This study looks at the best ways to offer long-acting injectable PrEP (a shot to prevent HIV) in clinics. It involves clinic staff and a review of patient records to improve how this prevention option is delivered.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study looks at how people in the Washington, DC area use HIV prevention services. It focuses on those who are HIV-negative and either new to PrEP, taking daily PrEP pills, or getting long-acting injectable PrEP.
Hear when a new Health-Related Social Needs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.